Carteolol is generally well-tolerated.
Side effects are usually mild and transient.
Nervous system side effects include headache in up to  to , asthenia in , insomnia in , dizziness in , paresthesias in , and vertigo, nervousness, headache or fatigue in  of patients.
Cardiovascular problems include chest pain in  and edema in  of patients.
Carteolol may cause or worsen AV heart block.
In the rare cases of new or worsened congestive heart failure that are associated with carteolol, a cause-and-effect relationship is not established.
The etiology of "chest pain" was not described in studies and reviews from the medical literature.
Gastrointestinal complaints of abdominal or epigastric pain in  to  and diarrhea or nausea in  of patients is reported.
Respiratory side effects are rare.
Cough, pharyngitis, or sinusitis are reported in  to  of patients.
Dyspnea is reported rarely.
Patients with a history of reactive airways disease may be more likely to become short of breath while taking carteolol, as during therapy with any beta-blocker.
Musculoskeletal pain is reported in approximately  to  of patients.
Carteolol and pindolol, beta-adrenergic receptor antagonists with intrinsic sympathomimetic activity (ISA), have more commonly been associated with muscle cramps and elevated serum creatine phosphokinase (CK) levels than beta-blockers without ISA.
Genitourinary complaints of impotence are reported in less than  of male patients.
Psychiatric side effects including reports of depression have been associated with carteolol.